Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Oncobiologics- Inc. (ONS)

0.85 0 (0%)

06-20 16:00

Open:

0.85

Pre. Close:

0.85

High:

0.8672

Low:

0.85

Volume:

54,553

Market Cap:

27M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.872 - 0.876

0.876 - 0.88

Low:

0.838 - 0.844

0.844 - 0.849

Close:

0.842 - 0.851

0.851 - 0.858

Technical analysis  (as of: 2018-06-20 4:37:11 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 1.13     One year: 1.24

Support:

Support1: 0.82    Support2: 0.68

Resistance:

Resistance1: 0.97    Resistance2: 1.06

Pivot:

0.91

Moving Averages:

MA(5): 0.86     MA(20): 0.92

MA(100):     MA(250): 1.12

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 10.42     %D(3): 15.05

RSI:

RSI(14): 40.24

52-Week:

High: 2.3  Low: 0.782  Change(%): -25.4

Average Vol(K):

3-Month: 6360  10-Days 24748

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ONS has closed above bottom band by 16.4%. Bollinger Bands are 36.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-15T16:57:29-04:00
Oncobiologics misses by $0.09

2018-05-14T09:57:12-04:00
Oncobiologics secures $15M capital raise; shares down 5%

2018-02-14T09:29:42-05:00
Oncobiologics reports Q1 results

2018-01-29T08:18:26-05:00
Premarket analyst action - healthcare

2018-01-09T11:02:20-05:00
Your Daily Pharma Scoop: Ablynx Takeover Bid, Celgene Acquires Impact Biomedicines, Axovant Flops Again

2017-12-28T01:42:08-05:00
Your Daily Pharma Scoop: Portola BLA Review Process Delayed, DelMar Soars, Alexion Gets Nod For Soliris In Japan

2017-12-21T09:42:09-05:00
Your Daily Pharma Scoop: AEterna Zentaris Gets FDA Nod, Valeant Finalizes Sprout Sale, Roche Gets EC Approval

2017-12-07T12:44:45-05:00
Midday Gainers / Losers

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

32.33

Shares Float (M)

24.26

% Held by Insiders

31.60

% Held by Institutions

6.00

Shares Short (K)

78

Shares Short Prior Month (K)

408

Stock Financials

EPS

EPS Est. Current Year

-2.420

EPS Est. Next Year

-3.550

EPS Est. Next Quarter

-0.880

Forward EPS

-0.730

Book Value (p.s.)

50.040

PEG Ratio

Profit Margin

Operating Margin

-496.81

Return on Assets (ttm)

-173.1

Return on Equity (ttm)

124.2

Qtrly Rev. Growth

154.6

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-18.33

Levered Free Cash Flow (M)

-15.18

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

0.02

P/S

161650000.00

P/CF

-1.50

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.